Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Febbo PG, Lowenberg M, Thorner AR, Brown M, Loda M, Golub TR. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J Urol. 2005;173(5):1772-7.

Rubio CA, Nesi G, Zampi GC, de Ruiz PA, Jessurun J, Jónasson J, et al. Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins. J Clin Pathol. 2005;58(6):605-10.

Peng W, Zhang X, Mohamed N, Inghirami G, Takeshita K, Pecora A, et al. A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation. Cancer Immunol Immunother. 2005;54(12):1172-9.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, et al. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res. 2005;11(18):6650-6.

Ghinoi A, Mascia MT, Giuggioli D, Magistro R, Barbolini G, Magro CM, et al. Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection. Clin Exp Rheumatol. 2005;23(3):431-3.

Lechpammer M, Xu X, F Ellis H, Bhattacharaya N, Shapiro GI, Loda M. Flavopiridol reduces malignant transformation of the esophageal mucosa in p27 knockout mice. Oncogene. 2005;24(10):1683-8.

Witkiewicz AK, Hecht JL, Cviko A, McKeon FD, Ince TA, Crum CP. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Hum Pathol. 2005;36(2):154-61.

Manazza AD, Bonello L, Pagano M, Chiusa L, Novero D, Stacchini A, et al. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Am J Clin Pathol. 2005;124(2):182-90.

A Ackerman B. Decline of a discipline: abetment by journals. J Cutan Pathol. 2005;32(3):254; author reply 254.

Febbo PG, Richie JP, George DJ, Loda M, Manola J, Shankar S, et al. Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer. Clin Cancer Res. 2005;11(14):5233-40.